Primary percutaneous coronary intervention vs conservative treatment for acute ST elevation myocardial infarction - Short- and long-term follow-up according to disease severity

Circulation Journal

Volumn 72, Issue 9, 2008, Pages 1391-1396

  Koyanagi, Ryo ^a   Hagiwara, Nobuhisa ^a   Kasanuki, Hiroshi ^a   Tsurumi, Yukio ^a   Ogawa, Hiroshi ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Acute myocardial infarction; Percutaneous coronary intervention; Prognosis; Reperfusion therapy; TIMI risk score

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; NITRATE;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CARDIOVASCULAR RISK; COMPARATIVE STUDY; CONSERVATIVE TREATMENT; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; ST SEGMENT ELEVATION; STATISTICAL SIGNIFICANCE; UNIVERSITY HOSPITAL;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TIME FACTORS; TOKYO;

EID: 50449083194     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-07-0712     Document Type: Article

References (20)

1. Weaver WD, Simes RJ, Betriu A, Grines CL, Zijlstra F, Garcia E, et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review. JAMA 1997; 278: 2093-2098.
2. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials. Lancet 2003; 361: 13-20.
3. White HD, Assmann SF, Sanborn TA, Jacobs AK, Webb JG, Sleeper LA, et al. Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: Results from the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) trial. Circulation 2005; 112: 1992-2001.
4. Kaul P, Armstrong PW, Chang WC, Naylor CD, Granger CB, Lee KL, et al. Long-term mortality of patients with acute myocardial infarction in the United States and Canada: Comparison of patients enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I. Circulation 2004; 110: 1754-1760.
5. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al; American College of Cardiology, American Heart Association, Canadian Cardiovascular Society. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J Am Coll Cardiol 2004; 44: 671-719.
6. Krumholz HM, Anderson JL, Brooks NH, Fesmire FM, Lambrew CT, Landrum MB, et al; American College of Cardiology/American Heart Association Task Force on Performance Measures, Writing Committee to Develop Performance Measures on ST-Elevation and Non-ST-Elevation Myocardial Infarction. ACC/AHA clinical performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures on ST-Elevation and Non-ST-Elevation Myocardial Infarction). Circulation 2006; 113: 732-761.
7. Thune JJ, Hoefsten DE, Lindholm MG, Mortensen LS, Andersen HR, Nielsen TT, et al; Danish Multicenter Randomized Study on Fibrinolytic Therapy Versus Acute Coronary Angioplasty in Acute Myocardial Infarction (DANAMI)-2 Investigators. Simple risk stratification at admission to identify patients with reduced mortality from primary angioplasty. Circulation 2005; 112: 2017-2021.
8. Armstrong PW. A comparison of pharmacologic therapy with/without timely coronary intervention vs primary percutaneous intervention early after ST-elevation myocardial infarction: The WEST (Which Early ST-elevation myocardial infarction Therapy) study. Eur Heart J 2006; 27: 1530-1538.
9. Kasanuki H, Honda T, Haze K, Sumiyoshi T, Horie T, Yagi M, et al; HIJAMI Investigators. A large-scale prospective cohort study on the current status of therapeutic modalities for acute myocardial infarction in Japan: Rationale and initial results of the HIJAMI Registry. Am Heart J 2005; 150: 411-418.
10. Yamaguchi J, Kasanuki H, Nagashima M, Koyanagi R, Ogawa H, Hagiwara N, et al; The Heart Institute of Japan, Cardiology (HIJC) Investigators. Serum creatinine on admission predicts long-term mortality in acute myocardial infarction patients undergoing successful primary angioplasty. Circ J 2007; 71: 1354-1359.
11. Koganei H, Kasanuki H, Ogawa H, Tsurumi Y. Association of glomerular filtration rate with unsuccessful primary percutaneous coronary intervention and subsequent mortality in patients with acute myocardial infarction. Circ J 2008; 72: 179-186.
12. Morrow DA, Antman EM, Charlesworth A, Cairns R, Murphy SA, de Lemos JA, et al. TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 2000; 102: 2031-2037.
13. Morrow DA, Antman EM, Parsons L, de Lemos JA, Cannon CP, Giugliano RP, et al. Application of the TIMI risk score for ST-elevation MI in the National Registry of Myocardial Infarction 3. JAMA 2001; 286: 1356-1359.
14. Rogers WJ, Canto JG, Lambrew CT, Tiefenbrunn AJ, Kincaid B, Shoultz DA, et al. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the U.S. from 1990 through 1999: The National Registry of Myocardial Infarction 1, 2 and 3. J Am Coll Cardiol 2000; 36: 2056-2063
15. Kinjo K, Sato H, Sakata Y, Nakatani D, Mizuno H, Shimizu M, et al; on Behalf of the Osaka Acute Coronary Insufficiency Study (OACIS) Group. Identification of uncomplicated patients with acute myocardial infarction undergoing percutaneous coronary intervention: Are these patients suitable for early discharge? Circ J 2005; 69: 1163-1169.
16. Ishihara M, Kojima S, Sakamoto T, Asada Y, Tei C, Kimura K, et al; Japanese Acute Coronary Syndrome Study Investigators. Acute hyperglycaemia is associated with adverse outcome after acute myocardial infarction in the coronary intervention era. Am Heart J 2005; 150: 814-820.
17. Fox KA, Philippe GS, Eagle KA, Goodman SG, Anderson FA, Granger CB, et al; GRACE Investigators. Decline in rate of death and heart failure in acute coronary syndoromes, 1999-2006. JAMA 2007; 297: 1892-1900.
18. Grines CL, Browne KF, Marco J, Rothbaum D, Stone GW, O'Keefe J, et al, for The Primary Angioplasty in Myocardial Infarction Study Group. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction: The Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 1993; 328: 673-679.
19. Widimsky P, Budesinsky T, Vorac D, Groch L, Zelizko M, Aschermann M, et al; 'PRAGUE' Study Group Investigators. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction: Final results of the randomized national multicentre trial (PRAGUE-2). Eur Heart J 2003; 24: 94-104.
20. Menotti A, Puddu PE, Lanti M, Kromhout D, Blackburn H, Nissinen A. Twenty-five-year coronary mortality trends in the seven countries study using the accelerated failure time model. Eur J Epidemiol 2003; 18: 113-122.